Konvomep™ (omeprazole/sodium bicarbonate) – New drug approval
August 30, 2022 - The FDA approved Azurity Pharmaceuticals’ Konvomep (omeprazole/sodium bicarbonate) for oral suspension, in adults for: short-term treatment (4 to 8 weeks) of active benign gastric ulcer and reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.
Top